Delivery Order SPE2DB22D3011-SPE2DB24FP9PL
Award Date
3/1/24
Potential Completion Date
3/4/24
Potential Value
$8.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,973.16 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and holds a larger indefinite delivery contract with DLA worth up to $999,999,999.00...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The delivery order has a potential value of $4,787.08 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,448,571 units of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The order has a potential value of $2,630.88 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,428.06 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a delivery date of April 4, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $3,634.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. This delivery order falls under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563458687 ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a potential value of $1,094.52 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is responsible for delivering these pharmaceutical products to support military treatment programs and...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 162 mg/0.9 mL ACTEMRA syringes. The $5,618.86 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a broader indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, to supply a range of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, with a potential value of $5,351.04 and a completion date of February 5, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a potential value of $6,882.23 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products. The $1,973.16 contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...